• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜分支静脉阻塞行动静脉鞘膜切开术后视觉预后的配对对照研究。

Matched control study of visual outcomes after arteriovenous sheathotomy for branch retinal vein occlusion.

作者信息

Yamane Shin, Kamei Motohiro, Sakimoto Susumu, Inoue Maiko, Arakawa Akira, Suzuki Mihoko, Matsumura Nagakazu, Kadonosono Kazuaki

机构信息

Department of Ophthalmology, Yokohama City University Medical Center, Yokohama, Japan.

Department of Ophthalmology, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

Clin Ophthalmol. 2014 Feb 26;8:471-6. doi: 10.2147/OPTH.S58681. eCollection 2014.

DOI:10.2147/OPTH.S58681
PMID:24600201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3942218/
Abstract

BACKGROUND

The purpose of this study was to evaluate visual outcomes of arteriovenous sheathotomy for macular edema due to branch retinal vein occlusion (BRVO).

METHODS

The medical records of 45 eyes from 45 patients who had undergone vitrectomy surgery with arteriovenous sheathotomy for BRVO were studied. Forty-five eyes of 45 patients with a BRVO but without intervention were studied as the control group. The best-corrected visual acuity and central macular thickness were compared between the two groups at baseline and at 1, 3, 6, and 12 months postoperatively.

RESULTS

Improvement of best-corrected visual acuity was 0.42 logarithm of the minimum angle of resolution (logMAR) units in the sheathotomy group and 0.22 logMAR units in the control group (P=0.007). The mean postoperative central macular thickness was significantly thinner in the sheathotomy group at 1 month (P=0.01), but not at 3, 6, and 12 months (P=0.75, P=0.81, and P=0.46, respectively). Improvement of best-corrected visual acuity at 12 months was significantly correlated with baseline best-corrected visual acuity, age, duration of symptoms, and sheathotomy (P<0.05).

CONCLUSION

Arteriovenous sheathotomy for BRVO improves best-corrected visual acuity significantly more than the natural course of the BRVO disease process.

摘要

背景

本研究旨在评估视网膜分支静脉阻塞(BRVO)所致黄斑水肿行动静脉鞘膜切开术的视力预后。

方法

对45例因BRVO接受玻璃体切割联合动静脉鞘膜切开术患者的45只眼的病历进行研究。将45例BRVO但未接受干预的患者的45只眼作为对照组。比较两组在基线时以及术后1、3、6和12个月时的最佳矫正视力和中心黄斑厚度。

结果

鞘膜切开术组最佳矫正视力提高了0.42最小分辨角对数(logMAR)单位,对照组提高了0.22 logMAR单位(P = 0.007)。鞘膜切开术组术后1个月时平均中心黄斑厚度明显更薄(P = 0.01),但在3、6和12个月时并非如此(分别为P = 0.75、P = 0.81和P = 0.46)。12个月时最佳矫正视力的改善与基线最佳矫正视力、年龄、症状持续时间和鞘膜切开术显著相关(P < 0.05)。

结论

BRVO行动静脉鞘膜切开术比BRVO疾病自然进程能更显著地提高最佳矫正视力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c0/3942218/fad35137f36a/opth-8-471Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c0/3942218/17821fd38047/opth-8-471Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c0/3942218/12fce59f71b5/opth-8-471Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c0/3942218/fad35137f36a/opth-8-471Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c0/3942218/17821fd38047/opth-8-471Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c0/3942218/12fce59f71b5/opth-8-471Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c0/3942218/fad35137f36a/opth-8-471Fig3.jpg

相似文献

1
Matched control study of visual outcomes after arteriovenous sheathotomy for branch retinal vein occlusion.视网膜分支静脉阻塞行动静脉鞘膜切开术后视觉预后的配对对照研究。
Clin Ophthalmol. 2014 Feb 26;8:471-6. doi: 10.2147/OPTH.S58681. eCollection 2014.
2
Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion.视网膜分支静脉阻塞行玻璃体切除术联合或不联合动静脉鞘膜切开术的长期预后
Retina. 2007 Jan;27(1):49-54. doi: 10.1097/01.iae.0000221996.77421.69.
3
Edaravone (MCI-186) is effective as a free radical scavenger following arteriovenous sheathotomy for treatment of macular oedema associated with branch retinal vein occlusion.依达拉奉(MCI-186)作为一种自由基清除剂,在动静脉鞘膜切开术后治疗与视网膜分支静脉阻塞相关的黄斑水肿方面有效。
Br J Ophthalmol. 2009 Nov;93(11):1479-82. doi: 10.1136/bjo.2008.154930. Epub 2009 Aug 9.
4
Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion.采用或不采用动静脉外膜鞘膜切开术的玻璃体切除术治疗与视网膜分支静脉阻塞相关的黄斑水肿。
Am J Ophthalmol. 2004 Dec;138(6):907-14. doi: 10.1016/j.ajo.2004.06.061.
5
Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment.玻璃体切除术联合动静脉外膜鞘膜切开术治疗视网膜分支静脉阻塞,手术性玻璃体后脱离的可能作用
Graefes Arch Clin Exp Ophthalmol. 2004 Mar;242(3):223-8. doi: 10.1007/s00417-003-0824-4. Epub 2003 Dec 18.
6
Evaluation of arteriovenous crossing sheathotomy for decompression of branch retinal vein occlusion.视网膜分支静脉阻塞减压的动静脉交叉鞘膜切开术评估
Eye (Lond). 2008 Jan;22(1):120-7. doi: 10.1038/sj.eye.6702633. Epub 2006 Oct 27.
7
Visual acuity and multifocal electroretinographic changes after arteriovenous crossing sheathotomy for macular edema associated with branch retinal vein occlusion.视网膜分支静脉阻塞相关黄斑水肿行动静脉交叉鞘膜切开术后的视力及多焦视网膜电图变化
Retina. 2008 Feb;28(2):220-5. doi: 10.1097/IAE.0b013e31813c69df.
8
Sheathotomy to decompress branch retinal vein occlusion: a matched control study.视网膜静脉分支阻塞减压的鞘膜切开术:一项匹配对照研究。
Ophthalmology. 2004 Mar;111(3):540-5. doi: 10.1016/j.ophtha.2003.05.032.
9
Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema.视网膜分支静脉阻塞合并黄斑水肿行动静脉鞘膜切开术后的视觉预后及玻璃体细胞因子水平
Acta Ophthalmol. 2008 Jun;86(4):377-84. doi: 10.1111/j.1600-0420.2007.01074.x. Epub 2007 Nov 26.
10
[The efficacy of arteriovenous adventitial sheathotomy for macular edema in branch retinal vein occlusion].[视网膜分支静脉阻塞性黄斑水肿的动静脉外膜鞘切开术疗效]
Nippon Ganka Gakkai Zasshi. 2004 Mar;108(3):144-9.

引用本文的文献

1
Vitrectomy for macular edema due to retinal vein occlusion.视网膜静脉阻塞所致黄斑水肿的玻璃体切除术
Clin Ophthalmol. 2019 Jun 13;13:969-984. doi: 10.2147/OPTH.S203212. eCollection 2019.
2
New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion.视网膜分支静脉阻塞的分类、发病机制、危险因素、自然史及治疗的新进展
J Ophthalmol. 2017;2017:4936924. doi: 10.1155/2017/4936924. Epub 2017 Mar 12.

本文引用的文献

1
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.雷珠单抗治疗视网膜分支静脉阻塞继发黄斑水肿的持续获益:一项 III 期研究的 12 个月结果。
Ophthalmology. 2011 Aug;118(8):1594-602. doi: 10.1016/j.ophtha.2011.02.022.
2
Economic considerations of macular edema therapies.黄斑水肿治疗的经济学考虑。
Ophthalmology. 2011 Sep;118(9):1827-33. doi: 10.1016/j.ophtha.2010.12.034. Epub 2011 Apr 20.
3
Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1).
玻璃体内注射贝伐单抗与假治疗急性视网膜分支静脉阻塞伴黄斑水肿:3 个月的结果(报告 1)。
Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):193-200. doi: 10.1007/s00417-010-1440-8. Epub 2010 Aug 18.
4
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.一项比较玻璃体内注射曲安奈德与标准治疗方案治疗视网膜分支静脉阻塞继发黄斑水肿所致视力丧失的疗效和安全性的随机试验:视网膜静脉阻塞的标准治疗与皮质类固醇治疗(SCORE)研究报告6
Arch Ophthalmol. 2009 Sep;127(9):1115-28. doi: 10.1001/archophthalmol.2009.233.
5
Long-term visual outcome of arteriovenous adventitial sheathotomy on branch retinal vein occlusion induced macular edema.视网膜分支静脉阻塞所致黄斑水肿的动静脉外膜鞘切开术的长期视觉预后
Korean J Ophthalmol. 2008 Mar;22(1):1-5. doi: 10.3341/kjo.2008.22.1.1.
6
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗视网膜分支静脉阻塞继发的黄斑水肿。
Retina. 2007 Apr-May;27(4):419-25. doi: 10.1097/IAE.0b013e318030e77e.
7
Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion.视网膜分支静脉阻塞行玻璃体切除术联合或不联合动静脉鞘膜切开术的长期预后
Retina. 2007 Jan;27(1):49-54. doi: 10.1097/01.iae.0000221996.77421.69.
8
Cataract formation and other complications of intravitreal triamcinolone for macular edema.玻璃体内注射曲安奈德治疗黄斑水肿导致的白内障形成及其他并发症。
Am J Ophthalmol. 2006 Apr;141(4):629-37. doi: 10.1016/j.ajo.2005.11.050.
9
Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.玻璃体内注射曲安奈德治疗视网膜分支静脉阻塞相关的缺血性黄斑水肿。
Am J Ophthalmol. 2006 May;141(5):876-883. doi: 10.1016/j.ajo.2005.12.011. Epub 2006 Mar 9.
10
Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.玻璃体内注射曲安奈德治疗视网膜分支静脉阻塞继发的黄斑水肿。
Retina. 2005 Oct-Nov;25(7):851-5. doi: 10.1097/00006982-200510000-00006.